Connect with us

Health

Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients – Gizmodo Australia

New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs — at least for some patients. This is counter…

Published

on

Article feature image

New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs at least for some patients. This is counter to a common industry claim that patients arent affected by list price increases. The study found a link between list prices rising and out-of-pocket increases among people with private insurance plans that mandated deductibles and coinsurance. These patients also didnt seem to benefit from rebates passed down by drug makers to insurance…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Six new COVID-19 cases in Victorian hotel quarantine – ABC News
Article feature image
Mum describes heartache after baby’s death at 12-days-old after sensing something was off – nation.lk – The Nation Newspaper